Home / Irinotecan / Switzerland
CH ATC L01CE02 · updated 2 Nov 2026
Irinotecan shortage in Switzerland
Is there an Irinotecan shortage in Switzerland?
Yes. As of 2 Nov 2026, 5 Irinotecan products are reported short in Switzerland, the first since 3 Nov 2025. The company estimate for the return is 27 Nov 2026. Main reason: not stated.
Also short in United States, Canada, Italy, Belgium. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | IRINOTECAN Sandoz eco 500 mg/25ml Durchstf 25 ml | Sandoz Pharmaceuticals AG | 3 Nov 2025 | not given | Not stated |
| CH | IRINOTECAN Sandoz eco 300 mg/15ml Durchstf 15 ml | Sandoz Pharmaceuticals AG | 28 Sep 2026 | 27 Nov 2026 | Not stated |
| CH | CAMPTO Inf Konz 100 mg/5ml Durchstf 5 ml | Pfizer AG | 30 Sep 2026 | not given | Not stated |
| CH | CAMPTO Inf Konz 300 mg/15ml Durchstf 15 ml | Pfizer AG | 30 Sep 2026 | not given | Not stated |
| CH | CAMPTO Inf Konz 40 mg/2ml Durchstf 2 ml | Pfizer AG | 30 Sep 2026 | not given | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).